Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.46 |
| ▸ | ADH1B | P00325 | 1/20 | 0.43 |
| ▸ | ADH1C | P00326 | 1/20 | 0.43 |
| ▸ | ADH1A | P07327 | 1/20 | 0.43 |
| ▸ | ADH4 | P08319 | 1/20 | 0.43 |
| ▸ | ADH7 | P40394 | 1/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.41 |
| ▸ | FDPS | P14324 | 3/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10583127 | 1.00 | ACE2 (0.52) | ACE2OPRM1TSHRTHRBSPHK1 | |
| SCHEMBL4406595 | 1.00 | ACE2 (0.52) | ACE2OPRM1TSHRTHRBSPHK1 | |
| SCHEMBL5301671 | 1.00 | ACE2 (0.52) | ACE2OPRM1TSHRTHRBSPHK1 | |
| SCHEMBL671909 | 1.00 | ACE2 (0.52) | ACE2OPRM1TSHRTHRBSPHK1 | |
| SCHEMBL5294996 | 1.00 | ACE2 (0.52) | ACE2OPRM1TSHRTHRBSPHK1 | |
| SCHEMBL10579761 | 1.00 | ACE2 (0.52) | ACE2OPRM1TSHRTHRBSPHK1 | |
| SCHEMBL672720 | 1.00 | ACE2 (0.52) | ACE2OPRM1TSHRTHRBSPHK1 | |
| SCHEMBL450926 | 1.00 | ACE2 (0.52) | ACE2OPRM1TSHRTHRBSPHK1 | |
| SCHEMBL4406475 | 1.00 | ACE2 (0.52) | ACE2OPRM1TSHRTHRBSPHK1 | |
| SCHEMBL555207 | 1.00 | ACE2 (0.52) | ACE2OPRM1TSHRTHRBSPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250368594-A1 | COMPOSITIONS AND METHODS TO SEPARATE CANNABINOIDS FROM IMPURITIES BY CRYSTALLIZATION | NATURAL EXTRACTION SYS LLC (US) | 2025-12-04 | — | — | US | claimed |
| US-12391637-B2 | Methods to separate cannabinoids from impurities by crystallization | Natural Extraction Systems, LLC (US) | 2025-08-19 | — | — | US | claimed |
| US-20220396540-A1 | METHODS TO SEPARATE CANNABINOIDS FROM IMPURITIES BY CRYSTALLIZATION | Natural Extraction Systems, LLC (US) | 2022-12-15 | — | — | US | claimed |
| WO-2021096886-A1 | METHODS TO SEPARATE CANNABINOIDS FROM IMPURITIES BY CRYSTALLIZATION | Natural Extraction Systems, LLC (US) | 2021-05-20 | — | — | WO | claimed |
| US-20250368594-A1 | COMPOSITIONS AND METHODS TO SEPARATE CANNABINOIDS FROM IMPURITIES BY CRYSTALLIZATION | NATURAL EXTRACTION SYS LLC (US) | 2025-12-04 | — | — | US | disclosed |
| US-12391637-B2 | Methods to separate cannabinoids from impurities by crystallization | Natural Extraction Systems, LLC (US) | 2025-08-19 | — | — | US | disclosed |
| WO-2025096734-A1 | MICROCAPSULES | FMC CORPORATION (US) | 2025-05-08 | — | — | WO | disclosed |
| US-11993562-B2 | Methods for isolation and purification of cannabidiol (CBD) and terpenes from hemp | RJ LEE GROUP, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| EP-3383380-B1 | LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE | BIOZEP AS (NO) | 2023-01-04 | — | — | EP | disclosed |
| US-20220396540-A1 | METHODS TO SEPARATE CANNABINOIDS FROM IMPURITIES BY CRYSTALLIZATION | Natural Extraction Systems, LLC (US) | 2022-12-15 | — | — | US | disclosed |
| US-20220324780-A1 | METHODS FOR ISOLATION AND PURIFICATION OF CANNABIDIOL (CBD) AND TERPENES FROM HEMP | RJ LEE GROUP, INC. | 2022-10-13 | — | — | US | disclosed |
| CN-106650181-B | Method for calculating density of hydrocarbon compound | 中国石油化工股份有限公司 | 2021-08-06 | — | — | CN | disclosed |
| WO-2021096886-A1 | METHODS TO SEPARATE CANNABINOIDS FROM IMPURITIES BY CRYSTALLIZATION | Natural Extraction Systems, LLC (US) | 2021-05-20 | — | — | WO | disclosed |
| CN-106407635-B | A method of calculating hydrocarbon compound boiling point | 中国石油化工股份有限公司 | 2019-03-08 | — | — | CN | disclosed |
| CN-106446485-A | Method for calculating refractive index of hydrocarbon compounds | 中国石油化工股份有限公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-106407635-A | Method for calculating boiling point of hydrocarbon compound | 中国石油化工股份有限公司 | 2017-02-15 | — | — | CN | disclosed |
| CN-106383981-A | Hydrocarbons compound physics property calculating method | 中国石油化工股份有限公司 | 2017-02-08 | — | — | CN | disclosed |
| EP-3063190-A1 | CONDUCTING POLYMER, 1-OCTADECENE, POLYMER WITH 2,5 FURANDIONE, METAL SALTS | Laurino, Joseph P. (US) | 2016-09-07 | — | — | EP | disclosed |
| WO-2015066015-A1 | CONDUCTING POLYMER, 1-OCTADECENE, POLYMER WITH 2,5 FURANDIONE, METAL SALTS | LAURINO JOSEPH P (US) | 2015-05-07 | — | — | WO | disclosed |
| US-4425419-A | Photosensitive composition | HITACHI, LTD. (JP) | 1984-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220324780-A1 | METHODS FOR ISOLATION AND PURIFICATION OF CANNABIDIOL (CBD) AND TERPENES FROM HEMP | CNR2, CNR1, CYP8B1 | ACE2 3185/4885OPRM1 619/4885TSHR 4403/4885 |
| US-11993562-B2 | Methods for isolation and purification of cannabidiol (CBD) and terpenes from hemp | CNR2, CNR1, CYP8B1 | ACE2 3185/4885OPRM1 619/4885TSHR 4403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.